In this episode of SciBud, join your science buddy Maple as we explore groundbreaking research on metabolic dysfunction-associated steatotic liver disease (MASLD), a condition now affecting nearly 30% of the global population. Tune in as we unpack a recent review that delves into the role of fibrosis in MASLD, highlighting how cutting-edge technologies like single-cell RNA sequencing and spatial omics are revolutionizing our understanding of this chronic liver disease. Discover how these advancements reveal the complex interactions between liver cells and immune responses that drive fibrosis progression, shedding light on potential new therapies tailored to individual patient profiles. While the findings are exciting, we'll also discuss critiques regarding data accessibility and statistical rigor, emphasizing the need for transparency in research. Get ready to delve into the intricacies of liver health and the future of personalized medicine in this informative and engaging episode—stay curious and keep exploring with us! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/165
Fler avsnitt av SciBud: Emerging Discoveries from Bioimaging
Visa alla avsnitt av SciBud: Emerging Discoveries from BioimagingSciBud: Emerging Discoveries from Bioimaging med Galo Garcia finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
